130 related articles for article (PubMed ID: 21546127)
1. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer].
Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM
Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127
[No Abstract] [Full Text] [Related]
2. Nasoalveolar cyst as a cause of false positive result in post-therapy 131I whole body scintigraphy.
García-Talavera P; Ruiz MÁ; Montes AA; Gamazo C; González ML; Olmos R
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):288-9. PubMed ID: 23067534
[No Abstract] [Full Text] [Related]
3. Accumulation of (131)INa activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer.
Castillo-Berrio C; Zelaya F; Loira F; Castrillón M; López A; Outomuro J
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):70-1. PubMed ID: 26144698
[No Abstract] [Full Text] [Related]
4. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
5. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine.
Borsò E; Boni G; Mazzarri S; Cocciaro A; Gambacciani C; Traino AC; Manca G; Grosso M; Scatena C; Ortenzi V; Vannozzi R; Marzola MC; Rubello D; Mariani G
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):111-5. PubMed ID: 25455505
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
7. Thyroid carcinoma in a newborn: clinical challenges in managing the first recorded case.
Estevão-Costa J; Gil-Da-Costa MJ; Medina AM; Sobrinho-Simões M
Med Pediatr Oncol; 2000 Apr; 34(4):290-2. PubMed ID: 10742075
[No Abstract] [Full Text] [Related]
8. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
[TBL] [Abstract][Full Text] [Related]
9. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
10. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
13. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
15. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer].
García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C
Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596
[TBL] [Abstract][Full Text] [Related]
16. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma.
Andreas J; Brühl K; Eissner D
Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774
[No Abstract] [Full Text] [Related]
17. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016
[TBL] [Abstract][Full Text] [Related]
18. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
Tuncel M; Ozgen Kiratli P
Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
[No Abstract] [Full Text] [Related]
19. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
20. [Should thyroxine treatment be discontinued for four weeks before I(131) thyroid ablation?].
Luna R; Penín M; Seoane I; Alvarez E; Palmeiro R; García-Mayor R
Endocrinol Nutr; 2012 Apr; 59(4):227-31. PubMed ID: 22436880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
